Tribe Technology set to deliver healthy pipeline of orders from Tier-One miners. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,356.00
Bid: 12,390.00
Ask: 12,394.00
Change: 28.00 (0.23%)
Spread: 4.00 (0.032%)
Open: 12,364.00
High: 12,454.00
Low: 12,322.00
Prev. Close: 12,328.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

LONDON MARKET MIDDAY: Stocks higher amid US holiday-thinned trade

Tue, 04th Jul 2023 12:08

(Alliance News) - Stock prices in London were higher at midday on Tuesday, with the absence of US markets and any major economic releases keeping trade muted.

"With US markets closed for the 4th July holiday, it is expected to be a quieter-than-normal day of trading with the potential for wider swings on lower volumes," said Victoria Scholar, head of investment at interactive investor.

The FTSE 100 index was up 10.31 points, or 0.1%, at 7,537.57. The FTSE 250 was up 44.46 points, or 0.2%, at 18,552.23, and the AIM All-Share was up 0.95 of a point, or 0.1%, at 755.28.

The Cboe UK 100 was up 0.1% at 751.83, the Cboe UK 250 was up 0.3% at 16,240.33, and the Cboe Small Companies was up 0.2% at 16,240.33.

Though Tuesday's economic calendar is quiet, the rest of the week will be busier, particularly in the US.

The US Federal Open Market Committee will publish its latest meeting minutes on Wednesday and a series of US jobs data will be released on Thursday and Friday.

"While the potential for further hawkish pricing for the Fed seems limited, there is a good chance of a dovish readjustment in the case of soft jobs data," said Ipek Ozkardeskaya, senior analyst at Swissquote Bank.

According to the CME FedWatch Tool, markets currently see an 87% chance the US central bank will hike interest rates by 25 basis points at its next meeting.

The dollar was slightly weaker on Tuesday afternoon, though Francesco Pesole at ING noted that volatility for the US currency will likely pick up from Wednesday with the release of the FOMC minutes.

The pound was quoted at USD1.2710 at midday on Tuesday in London, up from USD1.2675 at the close on Monday. The euro stood at USD1.0903, virtually unchanged against USD1.0905 on Monday. Against the yen, the dollar was trading at JPY144.39, lower compared to JPY144.59.

In London, AstraZeneca was the top blue-chip performer at midday on Tuesday, up 2.5%.

The stock had closed 4.9% lower on Monday as test results suggested its new lung cancer drug may be less successful than hoped, despite being generally positive.

Meanwhile, Sainsbury's was among the worst performers in the FTSE 100, down 1.4%, despite reporting an improved first quarter, with grocery sales on the up.

The grocer said in the 16 weeks to June 24, total retail sales excluding fuel grew 9.2% annually. Like-for-like sales climbed 9.8% on-year, also excluding fuel. Fuel sales alone fell 21%.

Sainsbury's said first-quarter growth was led by convenience stores and supermarkets, with customers continuing to return to stores.

Zoe Gillespie, investment manager at RBC Brewin Dolphin, said the results were "resilient".

"In an environment that many feared would lead to customers trading down, the supermarket continues to grow sales and its guidance for the year is largely unchanged...With a relatively strong balance sheet, excess cash flow, and growing market share, Sainsbury's looks well placed among its peers," she said.

In the FTSE 250, Wizz Air added 1.8%.

The Budapest-based budget airline carried 5.3 million passengers in June, up 23% from 4.3 million a year before and 6.0% from 5.0 million in May.

Wizz Air's planes were 92.2% full last month, up from 86.1% in June 2022 and 90.2% in May.

Russ Mould, investment director at AJ Bell commented low-cost airlines were having "a whale of a time" thanks to the sharp rebound in travel demand.

"The decision to expand fleet capacity during the cost-of-living crisis was a calculated risk and the move is now paying off," he said.

Elsewhere in London, Foresight Group added 0.9% following a largely strong set of annual results.

The infrastructure and private equity investment manager said revenue in the year ended March 31 increased by 38% to GBP119.2 million from GBP86.1 million the prior year.

Assets under management at March 31 climbed by 38% to GBP12.2 billion from GBP8.8 billion the year before, while funds under management were up by 35% to GBP9.0 billion from GBP6.7 billion year-on-year.

On AIM, Alba Minerals surged 53% after the Europe-focused mineral explorer announced it had been granted the ecological permits it requires for its planned dewatering and the exploration of the Clogau-St David's Gold Mine in North Wales.

The company has sought ecological permits to enable it to start the dewatering process since 2021.

Alba Mineral's technical team and contracts are now undertaking the necessary on-site preparations so that the dewatering exercise can start as soon as possible.

In European equities on Tuesday, the CAC 40 in Paris was down 0.1%, while the DAX 40 in Frankfurt was down 0.3%.

Brent oil was quoted at USD75.61 a barrel at midday in London on Tuesday, down a touch from USD75.92 late Monday. Gold was quoted at USD1,928.81 an ounce, slightly higher against USD1,927.00.

By Heather Rydings, Alliance News senior economics reporter

Comments and questions to newsroom@alliancenews.com

Copyright 2023 Alliance News Ltd. All Rights Reserved.

More News
3 May 2024 12:17

CORRECT: Angle shares up on assay development deal with AstraZeneca

(Correcting company name in headline)

Read more
3 May 2024 11:50

Angle shares up on assay development deal with AstraZenaca

(Alliance News) - Shares in Angle PLC jumped on Friday, after the company said it has been chosen to develop a prostate cancer assay using its Parsortix technology, opening the door for future clinical study-supporting contracts.

Read more
3 May 2024 07:50

LONDON BRIEFING: InterContinental Hotels makes first-quarter progress

(Alliance News) - London's FTSE 100 is called to open higher on Friday, on the expectation of a softer US jobs report, which could take some sting out of hawkish Federal Reserve interest rate expectations.

Read more
2 May 2024 10:04

AstraZeneca notes positive trial results for Calquence treatment

(Alliance News) - AstraZeneca PLC on Thursday said it observed positive high-level results in the Echo phase 3 trial of its Calquence treatment for previously untreated adult patients with mantle cell lymphoma.

Read more
2 May 2024 07:45

AstraZeneca reports positive results from blood cancer drug trial

(Sharecast News) - AstraZeneca has reported positive results from the use of its Calquence drug in a clinical trial to treat a rare type of blood cancer.

Read more
29 Apr 2024 22:52

J&J, Bristol Myers lose challenges to US drug price negotiation program

April 29 (Reuters) - A U.S. judge on Monday rejected a challenge by Bristol Myers Squibb and Johnson & Johnson to a law requiring them to negotiate the prices of their blockbuster blood clot prevention drugs with the U.S government's Medicare health insurance program or pay heavy penalties.

Read more
29 Apr 2024 10:02

LONDON BROKER RATINGS: Deutsche Bank likes Frasers; Barclays cuts JD

(Alliance News) - The following London-listed shares received analyst recommendations Monday morning and Friday:

Read more
29 Apr 2024 09:13

AstraZeneca makes progress with Truqap and Enhertu cancer treatments

(Alliance News) - AstraZeneca PLC on Monday said its Truqap drug has been recommended for approval in the EU to treat a form of breast cancer, while also noting trial results for its Enhertu offering.

Read more
29 Apr 2024 07:50

LONDON BRIEFING: Hipgnosis Songs Fund backs new Blackstone bid

(Alliance News) - London's FTSE 100 is called to open higher on Monday, with heady gains for US tech stocks on Friday brightening the mood in Europe and Asia at the start of the new week.

Read more
29 Apr 2024 07:24

AstraZeneca makes progress with two breast cancer treatments

(Sharecast News) - AstraZeneca issued favourable updates on two of its breast cancer treatments on Monday - 'Truqap', or capivasertib, and 'Enhertu', or trastuzumab deruxtecan - following encouraging results from respective phase three trials.

Read more
26 Apr 2024 09:33

LONDON BROKER RATINGS: Peel Hunt cuts ConvaTec to 'reduce'

(Alliance News) - The following London-listed shares received analyst recommendations Friday morning:

Read more
25 Apr 2024 16:57

LONDON MARKET CLOSE: FTSE 100 shakes off red-hot US inflation gauge

(Alliance News) - London's FTSE 100 outperformed on Thursday, enjoying a solid rise on largely well-received corporate earnings and a share price jump for miner Anglo American after it received a takeover bid from peer BHP.

Read more
25 Apr 2024 15:14

London close: Stocks finish mixed as US GDP growth slows

(Sharecast News) - London's stock markets finished with a mixed performance on Thursday, as investors digested a slower-than-expected GDP growth reading from the United States, while a slew of well-received earnings underpinned the top-flight index.

Read more
25 Apr 2024 11:50

LONDON MARKET MIDDAY: FTSE 100 hits high on offer for Anglo American

(Alliance News) - The FTSE 100 was outperforming European markets at midday on Thursday, with the index boosted to a record high thanks to takeover talks.

Read more
25 Apr 2024 10:33

AstraZeneca leaps after smashing first-quarter forecasts

Q1 revenue up 19% to $12.68 bln

*

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.